You might not think it would be possible to lose a buck in the marijuana business. In the nation’s capital, you’d apparently be wrong.
“All medical marijuana businesses are operating at a loss,” D.C. dispensary Capital City Care’s general manager David Guard told the Washington Times.
“So far, all we have been doing is bleeding cash,” Bob Simmons, with one of D.C.’s six approved cultivation centers, Alternative Solutions, said to the paper.
D.C.’s medical marijuana program has been operational for some three months now. In that time, only 59 patients have been added to the registry of legal buyers, reports the Washington Post:
The city’s pioneering dispensaries say they are losing money; doctors remain fearful to write prescriptions; and patients with HIV or cancer who may legally obtain the drug say they have been stymied by lengthy applications and warnings that the purchases remain illegal under federal law.
Those were among the many warnings that advocates for a robust medical marijuana program ticked off Monday at a hearing, as they urged D.C. council members to relax the city’s strict medical marijuana standards.
Advocates are asking that the District’s program be expanded, since current regulations allow medical marijuana to be prescribed only to patients with cancer, glaucoma, HIV/AIDS or a condition that causes severe muscle spasms. D.C.’s program is among the country’s most restrictive; other jurisdictions are far more expansive, allowing marijuana to be prescribed for such conditions as anorexia and migraine, Post-Traumatic Stress Disorder, nausea and Hepatitis C.
– Read the entire article at The Huffington Post.